He received his PhD in Computational Science from San Diego State University and subsequently completed a 3-year postdoctoral fellowship at the University of California, San Diego. Dr. Xu's research group pursues a broad range of multi-disciplinary translational projects in molecular-targeted therapeutics design and patient-centered pharmaceutical outcomes. Dr. Xu has been funded by ISU Faculty Seed Grant, Skaggs Foundation, Idaho Beef Council, and Mountain West CTR-IN, which supported the computational and clinical data resources in his laboratory.